The Securities and Exchange Commission announced insider trading charges against Congressman Christopher Collins, his son, and another associated individual. Collins allegedly tipped off his son, using information received in confidence as the director of a biotech company. Two additional associated individuals settled charges with the SEC.
August 8, 2018
New York congressman charged with insider trading
Related by Topic
February 2, 2024 News Alert
January 30, 2024 News Alert
Two co-defendants plead guilty in connection with insider trading scheme involving former Alexion executive
January 28, 2024 News Alert